Biostar Pharma (BSPM) Reports Q1 Loss of $0.28/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months Ended March 31, 2016
May 23, 2016 4:00 PM EDTXIANYANG, China, May 23, 2016 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced its financial results for the first quarter ended March 31, 2016.
During the fiscal first quarter of 2016, the Company recognized:
Net sales of $0.8 million, a decrease of approximately $6.1 million, or 88.4% as compared to the same period in 2015. Gross profit decreased by approximately $3.2 million, or 90.4% for the three months ended March 31, 2016 as... More